Phase 3 Clinical Studies in Alzheimer&#39;s and Parkinson&#39;s disease; Interim Analysis and FDA guidance for both indications

Posiphen (buntanetap) - Annovis Bio

Cheng Fang 1; Eve Damiano 1; Melissa Gaines 1; Michele Shaffer 2; Anne-Marie Nagy 3; Laurie Sanders 4; Maria Maccecchini1

Jul 4, 2023